In this section

Epidemiology and health economics

Epidemiology Understanding where the health burden is and whether new vaccines are likely to be cost-effective is essential for the implementation of vaccination programmes. This cross-cutting theme both supports vaccine development and assesses the outcome of vaccine implementation.

Vaccine-preventable diseases occur all over the world and in many cases may make the greatest impact in developing countries. It is essential that the spread of these infections is understood so that vaccine development can be prioritised appropriately, especially where certain high-risk groups are particularly affected.
As new vaccines become available, data about disease burden and the predicted benefits of vaccine uptake are necessary to understand whether a vaccine will be effective in the wider population and our ability to provide it to those in need.

Dr Victoria Cornelius
Senior Lecturer in Clinical Trial Statistics

Professor Andrea Crisanti
Professor of Molecular Parasitology

Professor Christl Donnelly
Professor of Statistical Epidemiology

Dr Ilaria Dorigatti
Lecturer/Sir Henry Dale Fellow

Professor Neil Ferguson
Professor of Mathematical Biology and Head of Department

Dr Tini Garske
Lecturer in Infectious Disease Analysis

Professor Azra Ghani
Chair in Infectious Disease Epidemiology

Professor Nicholas Grassly
Professor of Infectious Disease & Vaccine Epidemiology

Dr Katharina Hauck
Senior Lecturer in Health Economics

Professor Alison Holmes
Professor of Infectious Diseases

Dr Natsuko Imai
Research Associate

Krystal Lau
Research Postgraduate

Dr Marisa Miraldo
Associate Professor in Health Economics

Professor Peter Openshaw
Clinical Consul for the Faculty of Medicine

Professor Steven Riley
Professor of Infectious Disease Dynamics

Ana Wheelock Zalaquett
Honorary Research Associate

General enquiries

Clinical Senior Lecturer
Dr Christopher Chiu

vaccine.network@imperial.ac.uk
+44 (0)20 8383 2301